The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentamin PLC Regulatory News (CEY)

Share Price Information for Centamin PLC (CEY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 125.00
Bid: 125.40
Ask: 125.60
Change: 0.90 (0.73%)
Spread: 0.20 (0.159%)
Open: 124.90
High: 126.90
Low: 124.60
Prev. Close: 124.10
CEY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FCA Results Guidance and COVID-19 Update

25 Mar 2020 07:00

RNS Number : 4585H
Centamin PLC
25 March 2020
 

 

25 March 2020

 

 

 

 

 

Centamin plc 

("Centamin" or "the Company")

(LSE:CEY, TSX:CEE)

 

 

 

FCA Results Guidance and COVID-19 Update

 

 

Financial Conduct Authority ("FCA") moratorium on publication of results

On 21 March 2020, the FCA issued a strong request to all London listed companies to observe a moratorium on the publication of financial statements for a minimum of two weeks, due to the unprecedented global outbreak of coronavirus ("COVID-19").

In accordance with the FCA's request, Centamin will postpone publishing its 2019 Annual Results, for the twelve months ended 31 December 2019. As soon as we are advised by the FCA on updated timing, the Company will announce the date for the publication of its 2019 results.

For more information on the FCA request, please visit: https://www.fca.org.uk/news/statements/fca-requests-delay-forthcoming-announcement-preliminary-financial-accounts.

 

COVID-19

During these times of global uncertainty, our first priority is securing our corporate borders to protect the health, safety and wellbeing of our employees and communities. As of 24 March 2020, Centamin has no cases of COVID-19 amongst its workforce and has experienced no material disruption to operations, supply chain or gold shipments.

Early action was taken at Sukari, in line with our Severe Communicable Disease Outbreak Management Plan and the advice of governments and health authorities, to cease non-essential travel, adjust and manage on-site rosters, enable employees to work from home where possible, educate the workforce on the virus (symptoms and preventative measures), cease non-essential visitors, establish multiple mandatory checkpoints (Marsa Alam airport, community centre and mine gate) for possible symptoms and travel history screening for all visitors. Measures are in place to ensure all countries in which our people are located follow the advice of local government and health authorities.

A COVID-19 Executive Committee has been established with a clear management and site support framework in place, including daily workforce and supply chain risk reviews. As with many countries globally, Egypt has temporarily closed the national borders to civilian travel until 15 April 2020, but borders remain open to goods and supplies. To date, we have experienced no supply disruptions and have sufficient internationally sourced critical supplies stockpiled for the next quarter. We maintain open dialogue with our key international and domestic suppliers and, as a matter of caution, have assessed alternative potential supply channels. As the pandemic progresses we will continue to monitor the situation closely and will adapt our policies, procedures and controls to minimise potential impacts, within our control, to our business.

Centamin is a strong, resilient business with zero debt and US$348.9 million in cash and liquid assets, as at 31 December 2019.

 

 

 

For more information, please visit the website www.centamin.com or contact:

 

Centamin plc

Ross Jerrard, CEO

Alexandra Carse, Investor Relations

+44 (0) 7700 713 738

alexandra.carse@centamin.je

 

Buchanan

Bobby Morse

Chris Judd

Kelsey Traynor

+ 44 (0) 20 7466 5000

centamin@buchanan.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKQBQOBKDDNB
Date   Source Headline
18th Apr 202411:18 amRNSNotification of Major Holding(s)
18th Apr 20247:00 amRNSQ1 2024 Report
9th Apr 20245:32 pmRNS2023 Annual Report and Notice of AGM
9th Apr 20247:00 amRNS2023 Annual Report and Notice of AGM
2nd Apr 20247:00 amRNSAdditional Listing
27th Mar 20247:00 amRNS2023 Annual Report and Sustainability Report
21st Mar 20247:00 amRNS2023 Final Dividend
21st Mar 20247:00 amRNSPayments to Government
21st Mar 20247:00 amRNSFull Year 2023 Results
19th Mar 20247:00 amRNSNotification of Major Holding(s)
19th Mar 20247:00 amRNSNotification of Major Holding(s)
22nd Feb 20247:00 amRNSNotice of Full Year 2023 Results
24th Jan 20247:00 amRNSERRATUM – Group Resource and Reserve Statement
18th Jan 20247:00 amRNSQuarterly Report
10th Jan 20247:00 amRNSAppointment of Non-Executive Directors
9th Jan 20247:00 amRNSEncouraging Maiden EDX Drill Results
19th Dec 20232:45 pmRNSNotification of major holdings
19th Dec 20237:00 amRNSGroup Resource & Reserve Update 2023
29th Nov 202310:30 amRNSFavourable Final Egyptian Court Ruling
15th Nov 20235:19 pmRNSNotification of Major Holding(s)
19th Oct 20237:00 amRNSQuarterly Report
18th Oct 20237:00 amRNSNotice of Retail Investor Event
12th Oct 20237:00 amRNSSukari New Life of Mine Plan
6th Oct 20237:00 amRNSNotice of Investor and Analyst Event
19th Sep 20237:00 amRNSNotification of Major Holding(s)
12th Sep 20237:00 amRNSNotification of Major Holding(s)
17th Aug 202310:11 amRNSNotification of Major Holding(s)
26th Jul 20237:01 amRNSDividend Declaration
26th Jul 20237:00 amRNSInterim Results
20th Jul 202312:49 pmRNSNew Egyptian Mining Regulatory Framework Agreed
27th Jun 20237:00 amRNSPositive Doropo Gold Project Pre-feasibility Study
21st Jun 20238:34 amRNSStandard form for notification of major holdings
5th Jun 20234:07 pmRNSDirector/PDMR Shareholding
23rd May 20231:41 pmRNSResult of AGM
28th Apr 20237:00 amRNSTotal Voting Rights
26th Apr 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSPUBLICATION OF 2022 SUSTAINABILITY REPORT
20th Apr 20237:00 amRNSQuarterly Report
3rd Apr 20237:00 amRNSAdditional Listing
30th Mar 20237:00 amRNS2022 Annual Report and Notice of AGM
30th Mar 20237:00 amRNSCentamin's Decarbonisation Roadmap to 2030
23rd Mar 20231:50 pmRNSNotice of Director Dealing
21st Mar 20232:10 pmRNSNotification of Major Holding(s)
17th Mar 202310:41 amRNSNotice of Director Dealing
16th Mar 20237:02 amRNSPayments to Government
16th Mar 20237:01 amRNSFull Year 2022 Results
16th Mar 20237:00 amRNS2022 Final Dividend
24th Feb 20237:00 amRNSNotice of Full Year 2022 Results
19th Jan 20237:00 amRNSQUARTERLY REPORT
16th Jan 20237:00 amRNSLegal Update: Favourable Constitutional Ruling

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.